Mr Thomas Verstraeten | CEO
P95

Thomas Verstraeten is the CEO and founder of P95, a global CRO at the forefront of vaccine and infectious disease research. A medical doctor and epidemiologist by training, Thomas is a recognized leader in global health innovation, with a career spanning over 25 years across industry, government, and public health. Before establishing P95, he held senior scientific roles at GSK Vaccines and the U.S. Centers for Disease Control and Prevention (CDC), where he led high-impact vaccine safety and effectiveness initiatives. At P95, Thomas has built a dynamic, multinational organization trusted by global partners to deliver rigorous, real-world insights and accelerate clinical development.​